Technology is the largest hidden variable in most M&A transactions. Integration costs are routinely underestimated by 40-60%, timelines stretch past synergy capture windows, and the decisions made in the first 90 days after close determine whether the deal thesis is achievable. Having led technology integration for one of the largest pharmaceutical mergers in history — across 80+ countries with 300+ engineers — we understand the difference between integration planning on paper and integration execution under deal pressure.
We provide independent technology assessment that informs deal decisions and post-close execution. Evaluating target technology estates, quantifying integration risk and cost, designing integration architectures, and providing the ongoing advisory that keeps post-merger technology programs on trajectory when organizational complexity and timeline pressure compound.
Explore M&A Services
Technology Due Diligence
Independent technology assessment for M&A transactions. Evaluates target technology estates, identifies integration risks, quantifies true cost of ownership, and informs deal pricing and structure.
Post-Merger Integration
Technology integration advisory from Day 1 planning through synergy capture. Integration architecture design, program governance, and the strategic sequencing that keeps post-close programs on track.
Portfolio Technology Optimization
Technology portfolio rationalization for PE operating teams and multi-entity organizations. Identifies consolidation opportunities, shared services potential, and platform synergies across portfolio companies.
